Psychae Therapeutics
About:
Psychae Therapeutics focuses on developing medical-grade, botanically derived treatments to address serious mental health challenges.
Website: https://www.psychae.bio/
Top Investors: University of Melbourne, Tin Alley Ventures
Description:
Psychae Therapeutics develop innovative pharmaceutical grade DMT-based medicines and therapies aiming to transform the lives of those facing some of the most prolific and insidious mental illnesses
Total Funding Amount:
4.5M AUD
Headquarters Location:
Carlton, Victoria, Australia
Founded Date:
2022-01-01
Contact Email:
team(AT)psychae.bio
Founders:
Number of Employees:
1-10
Last Funding Date:
2023-11-12
IPO Status:
Private
Industries:
© 2025 bioDAO.ai